|By Marketwired .||
|June 20, 2014 06:00 AM EDT||
LONDON, ONTARIO -- (Marketwired) -- 06/20/14 -- Sernova Corp. (TSX VENTURE: SVA), a clinical stage company developing disruptive medical technologies for the long-term treatment of chronic diseases such as diabetes and haemophilia today was featured on BNN by news anchor Francis Horodelski.
Please refer to the segment using the following link:
Sernova Corp. is a clinical stage regenerative medicine company developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including haemophilia and other diseases treated through replacement of proteins or hormones missing or in short supply within the body. Sernova is developing the Cell Pouch, an implantable medical device for therapeutic cells (donor, xenogeneic or stem cells) which then release proteins and/or hormones as required. The therapeutic cells are protected from immune attack by Sernova's proprietary technologies.
This release may contain forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although Sernova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of Sernova's management on the date such statements were made. Sernova expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Sep. 27, 2016 06:30 PM EDT Reads: 3,554
Sep. 27, 2016 06:30 PM EDT Reads: 2,164
Sep. 27, 2016 06:15 PM EDT Reads: 340
Sep. 27, 2016 06:00 PM EDT Reads: 1,687
Sep. 27, 2016 05:45 PM EDT Reads: 1,653
Sep. 27, 2016 05:30 PM EDT Reads: 1,988
Sep. 27, 2016 05:15 PM EDT Reads: 284
Sep. 27, 2016 05:15 PM EDT Reads: 2,755
Sep. 27, 2016 05:00 PM EDT Reads: 1,593
Sep. 27, 2016 04:45 PM EDT Reads: 387
Sep. 27, 2016 04:00 PM EDT Reads: 2,649
Sep. 27, 2016 03:15 PM EDT Reads: 2,862
Sep. 27, 2016 03:15 PM EDT Reads: 2,759
Sep. 27, 2016 03:15 PM EDT Reads: 1,393
The many IoT deployments around the world are busy integrating smart devices and sensors into their enterprise IT infrastructures. Yet all of this technology – and there are an amazing number of choices – is of no use without the software to gather, communicate, and analyze the new data flows. Without software, there is no IT. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists will look at the protocols that communicate data and the emerging data analy...
Sep. 27, 2016 03:00 PM EDT Reads: 1,692